NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“Intelligent Bio Solutions,” “INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, ...

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...

Intelligent Bio Solutions Inc. reports significant account growth and expansion in new sectors, enhancing its drug screening technology's global presence. Intelligent Bio Solutions Inc. (INBS), a ...

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Tuesday reported a third quarter 2025 loss of 44 cents per share, down from a loss of $1.43 a year ago. The noninvasive testing solutions provider ...

The Company will be participating in one-on-one investor meetings throughout the event. For more information about the conference, or to schedule a meeting with the INBS management team, please ...

NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

The filing includes financial statements for the quarter, showing a decrease in revenue to $607,494 from $764,063 in the same quarter the previous year. The decrease is attributed to instability in ...

On Thursday, Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced preliminary fiscal second-quarter sales of approximately $0.61 million and six-month sales of roughly $1.48 million. Gross profit is ...